¼¼°èÀÇ ÆÄÁ¦Æ®º´ Ä¡·á ½ÃÀå º¸°í¼­(2025³â)
Paget Disease Treatment Global Market Report 2025
»óǰÄÚµå : 1730980
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,253,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,039,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,824,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ÆÄÁ¦Æ®º´ Ä¡·á ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ ¾ÈÁ¤µÈ ¼ºÀåÀÌ ¿¹»óµÉ ¿¹Á¤ÀÔ´Ï´Ù. ¿¹Ãø ±â°£ Áß ¼ºÀåÀº Ç¥Àû¿ä¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÇコÄɾî ÁöÃâ Áõ°¡, °í·ÉÈ­ Àα¸ Áõ°¡, ½Å±Ô ¿ä¹ýÀÇ ÀÓ»ó½ÃÇè Áõ°¡, ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ÁÖ¸ñ Áõ°¡ µî¿¡ ±âÀÎÇÑ´Ù°í »ý°¢µË´Ï´Ù.

°üÀý¿°ÀÇ Áõ·Ê ¼ö¿Í »À ¼Õ»ó Áõ°¡´Â ÆÄÁ¦Æ®º´ Ä¡·á ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀÇ Áõ°¡´Â ¿îµ¿ºÎÁ·°ú ¿¬°üµÇ¾î ÀÖÀ¸¸ç, ±ÙÀ°°ú °üÀýÀ» ¾àÈ­½ÃÄÑ ¿òÁ÷ÀÓÀ» º¸Á¶Çϰí Ãæ°ÝÀ» Èí¼öÇÏ´Â ´É·ÂÀ» ÀúÇϽÃŵ´Ï´Ù. ±× °á°ú, ½Ã°£ÀÇ °æ°ú¿Í ÇÔ²² °üÀýÀÇ º¯¼º, °æÁ÷, °ñÀýÀÇ ¸®½ºÅ©°¡ ³ô¾ÆÁý´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 2¿ù ¹Ì±¹À» °ÅÁ¡À¸·Î ÇÏ´Â °øÁßÀ§»ý±â°üÀÎ Áúº´´ëÃ¥¿¹¹æ¼¾ÅÍ(CDC)´Â 2022³â 18¼¼ ÀÌ»óÀÇ ¼ºÀÎÀÇ Áø´ÜµÈ °üÀý¿°ÀÇ ¿¬·ÉÁ¶Á¤À¯º´·üÀº 18.9%·Î ³²¼º(16.1%) ¶ÇÇÑ ¿©¼º(21.5%)ÀÌ ´õ ³ôÀº ¹ßº´·üÀ» º¸¿´½À´Ï´Ù°í º¸°íÇß½À´Ï´Ù.

ÆÄÁ¦Æ®º´ Ä¡·á ½ÃÀåÀÇ °¢ ȸ»ç´Â Ä¡·á È¿°úÀÇ Çâ»ó, ȯÀÚ °á°úÀÇ °³¼±, ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠Ȯ´ë¸¦ À§ÇØ Ä®½· Á¶Á¤Á¦ µîÀÇ Çõ½ÅÀûÀÎ Á¦Ç°ÀÇ °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. Ä®½· Á¶ÀýÁ¦´Â Ç÷¾×°ú »ÀÀÇ Ä®½· ³óµµ¸¦ Á¶ÀýÇÏ°í ´Ù¾çÇÑ »ý¸® ±â´ÉÀ» Áö¿øÇÏ´Â ±ÕÇüÀ» À¯ÁöÇÏ´Â µ¥ µµ¿òÀ̵Ǵ ¾à¹°°ú ¹°ÁúÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2025³â 2¿ù µ¶ÀÏÀÇ °Ç°­ °ü¸® ±â¾÷ÀÎ Fresenius Kabi AG´Â ÁõÈļº °ñÆÄÁ¦Æ®º´, °íÄ®½·Ç÷Áõ, Æó°æ ÈÄ °ñ´Ù°øÁõ Ä¡·á¸¦ ¸ñÀûÀ¸·Î ÇÏ´Â Ä®½· Á¶ÀýÁ¦ÀÎ Calcitonin Salmon Injection USP SyntheticÀ» Ãâ½ÃÇß½À´Ï´Ù. À̹ø Ãâ½Ã´Â º¸´Ù ºñ¿ë È¿À²ÀûÀÎ Ä¡·á ¿É¼ÇÀ» Á¦°øÇϰí, °ø±Þ¸ÁÀ» °­È­Çϰí, Á¦³Ê¸¯ ÁÖ»çÁ¦ÀÇ Æ÷Æ®Æú¸®¿À¸¦ È®´ëÇÏ´Â °ÍÀ» ¸ñÀûÀ¸·Î Çϰí ÀÖ½À´Ï´Ù. Fresenius Kabi´Â ¶ÇÇÑ ÇʼöÀûÀÎ ÀǾàǰÀÇ ¾ÈÁ¤ÀûÀÎ °ø±ÞÀ» º¸ÀåÇϱâ À§ÇØ ½Ã¼³¿¡ ´ë±Ô¸ð ÅõÀÚ¸¦ ½Ç½ÃÇϰí ÀÖÀ¸¸ç, ȯÀÚ ÄɾîÀÇ Çâ»ó°ú ¸®µù Çコ Äɾî ÇÁ·Î¹ÙÀÌ´õ·Î¼­ÀÇ ÁöÀ§ÀÇ È®¸³À» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª ¹ÙÀÌ·¯½º °¨¿°ÀÇ ¿µÇâ°ú ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Paget's disease is a chronic bone disorder marked by abnormal bone remodeling, which leads to weakened and enlarged bones. Treatment generally includes medications to regulate bone metabolism and manage symptoms, pain relievers, and, in some cases, surgery to address severe bone deformities.

The primary treatments for Paget's disease include Actonel, Reclast, Zoledronic acid, Fosamax, Miacalcin, Aredia, Calcitonin, Zometa, and other therapies. Actonel is a brand name for risedronate, a medication used to treat and prevent osteoporosis by strengthening bones. These treatments are administered through various routes, such as oral, intravenous, and topical, and are distributed via different channels, including hospital pharmacies, retail pharmacies, online pharmacies, and drug stores. The key end users of these treatments are hospitals, clinics, and other healthcare providers.

The paget disease treatment market research report is one of a series of new reports from The Business Research Company that provides paget disease treatment market statistics, including the paget disease treatment industry global market size, regional shares, competitors with the paget disease treatment market share, detailed paget disease treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the paget disease treatment industry. This paget disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The paget disease treatment market size has grown steadily in recent years. It will grow from $2.12 billion in 2024 to $2.21 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth during the historic period can be attributed to the rising prevalence of Paget's disease, increased awareness and diagnosis rates, an aging population, the expansion of healthcare infrastructure, and the growing adoption of bisphosphonates.

The paget disease market size is expected to see steady growth in the next few years. It will grow to $2.57 billion in 2029 at a compound annual growth rate (CAGR) of 3.9%. The growth during the forecast period can be attributed to the rising demand for targeted therapies, increasing healthcare expenditure, a growing aging population, more clinical trials for novel therapies, and a greater focus on personalized medicine. Key trends during this period include advancements in treatment options, a shift toward biologic treatments, the development of combination therapies, the integration of digital health solutions, and progress in diagnostic technologies.

The growing number of arthritis cases and bone injuries is expected to drive the growth of the Paget disease treatment market. Arthritis is a condition that causes joint inflammation, while bone injuries can also contribute to its development. The rise in these conditions is linked to physical inactivity, which weakens muscles and joints, reducing their ability to support movement and absorb impact. This leads to an increased risk of joint degeneration, stiffness, and fractures over time. Paget disease treatment plays a crucial role in managing arthritis and bone injuries by alleviating bone pain, improving joint function, and preventing complications such as fractures and deformities caused by abnormal bone remodeling. For example, in February 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based public health institute, reported that in 2022, the age-adjusted prevalence of diagnosed arthritis among adults aged 18 and older was 18.9%, with women (21.5%) showing a higher incidence than men (16.1%). The prevalence of arthritis increases with age, ranging from 3.6% in individuals aged 18-34 to 53.9% in those aged 75 and older. This rise in arthritis and bone injuries is driving the demand for Paget disease treatments.

Companies in the Paget disease treatment market are focusing on developing innovative products, such as calcium regulators, to improve treatment efficacy, enhance patient outcomes, and expand their market presence. A calcium regulator is a medication or substance that helps control calcium levels in the blood and bones, maintaining balance to support various physiological functions. For example, in February 2025, Fresenius Kabi AG, a Germany-based healthcare company, introduced Calcitonin Salmon Injection, USP Synthetic, a calcium regulator designed to treat symptomatic Paget's disease of the bone, hypercalcemia, and postmenopausal osteoporosis. This launch aims to provide a more cost-effective treatment option, strengthen their supply chain, and expand their portfolio of generic injectables. Fresenius Kabi has also invested significantly in its facilities to ensure a steady supply of essential medicines, aiming to enhance patient care and solidify its position as a leading healthcare provider.

In June 2024, Sun Pharmaceutical Industries Limited, an India-based pharmaceutical company, acquired Taro Pharmaceutical for approximately $347.73 million. This acquisition was intended to give Sun Pharma full control of Taro Pharmaceutical Industries Ltd., boosting its dermatology and specialty generics portfolio while streamlining operations and maximizing synergies. Taro Pharmaceutical Industries Ltd., an Israel-based company, specializes in generic and specialty medicines, including treatments for Paget's disease.

Major players in the paget disease treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Fresenius Kabi AG, Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Apotex Inc., Sumitomo Pharma Co. Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Endo International plc, Zaklady Farmaceutyczne Polpharma S.A., Abiogen Pharma S.p.A.

North America was the largest region in the paget disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in paget disease treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the paget disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The paget disease treatment market consists of revenues earned by entities by providing services such as diagnosis services, orthopedic services, genetic counseling services, and follow-up and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The paget disease treatment market also includes sales of pain management medications, calcium and vitamin D supplements, bone density monitoring devices, and assistive devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Paget Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on paget disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for paget disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The paget disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Paget Disease Treatment Market Characteristics

3. Paget Disease Treatment Market Trends And Strategies

4. Paget Disease Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Paget Disease Treatment Growth Analysis And Strategic Analysis Framework

6. Paget Disease Treatment Market Segmentation

7. Paget Disease Treatment Market Regional And Country Analysis

8. Asia-Pacific Paget Disease Treatment Market

9. China Paget Disease Treatment Market

10. India Paget Disease Treatment Market

11. Japan Paget Disease Treatment Market

12. Australia Paget Disease Treatment Market

13. Indonesia Paget Disease Treatment Market

14. South Korea Paget Disease Treatment Market

15. Western Europe Paget Disease Treatment Market

16. UK Paget Disease Treatment Market

17. Germany Paget Disease Treatment Market

18. France Paget Disease Treatment Market

19. Italy Paget Disease Treatment Market

20. Spain Paget Disease Treatment Market

21. Eastern Europe Paget Disease Treatment Market

22. Russia Paget Disease Treatment Market

23. North America Paget Disease Treatment Market

24. USA Paget Disease Treatment Market

25. Canada Paget Disease Treatment Market

26. South America Paget Disease Treatment Market

27. Brazil Paget Disease Treatment Market

28. Middle East Paget Disease Treatment Market

29. Africa Paget Disease Treatment Market

30. Paget Disease Treatment Market Competitive Landscape And Company Profiles

31. Paget Disease Treatment Market Other Major And Innovative Companies

32. Global Paget Disease Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Paget Disease Treatment Market

34. Recent Developments In The Paget Disease Treatment Market

35. Paget Disease Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â